CHINESE JOURNAL OF CT AND MRI, JUN. 2022, , Total Diagn patient's image was analyzed to compare the expression levels of CEA, CA125 and CA19-9 in different people. The accuracy, sensitivity, and specificity of MSCT, CEA, CA125, and CA19-9 alone and four
combined examinations in the diagnosis of ovarian cancer were compared. Results The expression (陕西 安康 725000) levels of CEA, CA125 and CA199 of patients with ovarian cancer were significantly higher than those of patients with ovarian benign diseases and of patients in healthy group (P<). There was no 【摘要】目的 分析MSCT联合血清癌胚抗原(CEA)、 significant difference between patients in healthy group and patients with ovarian benign disease 糖类抗原125(CA125)和糖类抗原19-9(CA199)对女 性卵巢癌的诊断价值。方法 回顾分析本院2017年 (P>). For the separate examination, there was no significant difference between two examinations 1月至2019年12月收治的88例卵巢癌患者的临床 at will (P>). The sensitivity, specificity and accuracy of MSCT+CEA+CA125+CA199 were 资料。另外选同期在本院治疗的卵巢良性疾病患 %, % and 97
